Multimeric t-cell modulatory polypeptides and methods of use thereof
US-2021284712-A1 · Sep 16, 2021 · US
Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus
Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/084 |
| Official title | Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus |
| Display label | Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus |
| Total patents | 138 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 9 |
| 2019 | 14 |
| 2020 | 14 |
| 2021 | 14 |
| 2022 | 13 |
| 2023 | 20 |
| 2024 | 16 |
| 2025 | 16 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Virus-like particle conjugates for diagnosis and treatment of tumors
US-11110181-B2 · Sep 7, 2021 · US
Novel il2 agonists and methods of use thereof
US-2021187027-A1 · Jun 24, 2021 · US
Anti-human papillomavirus 16 e7 t cell receptors
US-2021130432-A1 · May 6, 2021 · US
Cell penetrating conjugates and methods of use thereof
US-10967070-B2 · Apr 6, 2021 · US
HPV Proteins, Antibodies, and Uses in Managing Abnormal Epithelial Cell Growth
US-2020399348-A1 · Dec 24, 2020 · US
Anti-human papillomavirus 16 E7 T cell receptors
US-10870687-B2 · Dec 22, 2020 · US
Polyomavirus neutralizing antibodies
US-2020384109-A1 · Dec 10, 2020 · US
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
US-10806780-B2 · Oct 20, 2020 · US
Cutaneous papilloma virus vaccine
US-2020261563-A1 · Aug 20, 2020 · US
Diagnostic transcript and splice patterns of HR-HPV in different cervical lesions
US-10731228-B2 · Aug 4, 2020 · US
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
US-10730947-B2 · Aug 4, 2020 · US
HPV particles and uses thereof
US-10688172-B2 · Jun 23, 2020 · US
Polyomavirus neutralizing antibodies
US-2020190167-A1 · Jun 18, 2020 · US
Virus-like particle conjugates for diagnosis and treatment of tumors
US-2020188529-A1 · Jun 18, 2020 · US
Polyomavirus neutralizing antibodies
US-10654914-B2 · May 19, 2020 · US
Polypeptide vaccine
US-2020101147-A1 · Apr 2, 2020 · US
Virus-like particle conjugates for diagnosis and treatment of tumors
US-10588984-B2 · Mar 17, 2020 · US
Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
US-2020071390-A1 · Mar 5, 2020 · US
T cell receptors and engineered cells expressing same
US-2019321401-A1 · Oct 24, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/084?
- CPC C07K16/084 is the Cooperative Patent Classification code for “Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus.”
- How many patents are filed under CPC C07K16/084 (Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus)?
- Our database includes 138 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/084 growing?
- Publication counts under this code: 16 in 2024 vs 16 in 2025 (latest complete years).